Loading...

PODCAST

Pharmaceutical Executive

Pharmaceutical Executive Podcast

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.

science life sciences

All Episodes

2:26

Pharmaceutical Executive Daily: FDA Approves Datroway

Pharmaceutical Executive ·

2026/05/22

en-us

3:25

Pharmaceutical Executive Daily: What It Takes to Move...

Pharmaceutical Executive ·

2026/05/21

In today's Pharmaceutical Executive Daily, Reuters reports that lower-priced oral GLP-1 pills from Eli Lilly and Novo Nordisk are drawing patients away from compounded weight loss medications, Gilead Sciences' renews its five-year collaboration with WHO and Johnson and Johnson’s collaboration with the Department of Health Abu Dhabi, finally Partha Anbil argues that truly industrializing machine learning and AI in life sciences requires systems that are scientifically credible, clinically defensible,

en-us

3:34

Pharmaceutical Executive Daily: Eli Lilly Acquires...

Pharmaceutical Executive ·

2026/05/20

In today's Pharmaceutical Executive Daily, Eli Lilly announces a deal worth up to $202 million for Engage Biologics and its preclinical non-viral DNA delivery platform, two significant deals including Bristol Myers Squibb's enterprise-wide agreement to deploy Claude across its global operations and Incyte's expanded molecular AI collaboration with Genesis, and FDA grants two new early-stage breast cancer indications to Enhertu, marking trastuzumab deruxtecan's entry into the curative-intent setting

en-us

2:56

Pharmaceutical Executive Daily: TrumpRx Expands to...

Pharmaceutical Executive ·

2026/05/19

In today’s Pharmaceutical Executive Daily, the Trump administration expands TrumpRx to include more than 600 generic medicines, industry leaders rethink pharma’s traditional go-to-market model, and a biotech funding roundup highlights continued investment in early-stage therapeutics and radiopharmaceutical development.

en-us

21:26

Rethinking Pharma's Go-to-Market Formula

Pharmaceutical Executive ·

2026/05/19

In this episode of the Pharm Exec podcast, Mike Petroutsas, president and head of U.S. commercial at Astellas, shares the secrets to building a more agile commercial operating model — and mindset — equipped for today’s evolving engagement landscape. Drawing on examples from GI oncology, retina care, and women’s health, Petroutsas joins Mike Christel, group managing editor, MJH Life Sciences, to discuss how Astellas is tapping real-world insights, social listening and internal collaboration to

en-us

2:21

Pharmaceutical Executive Daily: FDA Approves Baxdrostat

Pharmaceutical Executive ·

2026/05/18

en-us

3:27

Pharmaceutical Executive Daily: FDA Approves...

Pharmaceutical Executive ·

2026/05/15

In today's Pharmaceutical Executive Daily, FDA approves AstraZeneca's Fasenra as a new treatment for hypereosinophilic syndrome in patients 12 years and older, the FDA places a full clinical hold on Aardvark Therapeutics' ARD-101 program, and BeOne Medicines co-founder and CEO John Oyler touches on building an oncology powerhouse from a disruptive idea and playing the long game on speed, science, and scale.

en-us

4:10

Pharmaceutical Executive Daily: FDA Approves Beqalzi...

Pharmaceutical Executive ·

2026/05/14

In today's Pharmaceutical Executive Daily, the FDA grants accelerated approval to BeOne Medicines' Beqalzi as the first and only BCL2 inhibitor for relapsed or refractory mantle cell lymphoma, while also approving Taiho Oncology's Inqovi in combination with venetoclax for newly diagnosed acute myeloid leukemia, Pharmaceutical Executive reports on the Doceree Makers Summit, and Dean Erhardt argues that AI-enabled workflow automation offers a practical path to fixing the prior authorization system's

en-us

3:25

Pharmaceutical Executive Daily: Rigel Pharmaceuticals...

Pharmaceutical Executive ·

2026/05/13

In today's Pharmaceutical Executive Daily, Rigel Pharmaceuticals enters an exclusive global licensing agreement with Arvinas and Pfizer for Veppanu, Eli Lilly releases data from two late-phase trials showing patients maintained meaningful weight loss after transitioning from higher-dose injectable GLP-1 therapies, and Hope Mueller argues that true pharmaceutical expertise is defined not just by having answers but by recognizing when you need a reset.

en-us

2:55

Pharmaceutical Executive Daily: GSK Enters...

Pharmaceutical Executive ·

2026/05/11

In today's Pharmaceutical Executive Daily, GSK enters an exclusive collaboration with Sino Biopharmaceutical's CTTQ subsidiary to accelerate the launch of bepirovirsen, the FDA approves Bizengri under the Commissioner's National Priority Voucher program, and President Trump has signed off on a plan to fire FDA Commissioner Marty Makary.

en-us

2:17

Pharmaceutical Executive Daily: FDA Extends Review of...

Pharmaceutical Executive ·

2026/05/08

In today’s Pharmaceutical Executive Daily, the FDA extends its priority review of a subcutaneous formulation of Leqembi, industry analysts examine how upcoming GLP-1 patent expirations could reshape the drug delivery device market, and experts discuss the key forces driving renewed growth in radiopharmaceuticals.

en-us

2:39

Pharmaceutical Executive Daily: Angelini Pharma...

Pharmaceutical Executive ·

2026/05/07

In today's Pharmaceutical Executive Daily, Angelini Pharma announces a $4.1 billion agreement to acquire Catalyst Pharmaceuticals, Incyte presents 24-week results from the Phase III TRuE-AD4 trial of Opzelura, and Pharmaceutical Executive speaks with Charlie Lyon of the API Innovation Center on what the conversation about bringing pharmaceutical manufacturing back to the United States is still missing.

en-us

9:56

Strengthening the Generic Drugs Supply Chain

Pharmaceutical Executive ·

2026/05/06

Natalie de Graaf, from the API Innovation Center, discusses a recent whitepaper detailing areas where the generic drugs pipeline is under stress.

en-us

3:09

Pharmaceutical Executive Daily: Zentalis Doses First...

Pharmaceutical Executive ·

2026/05/06

In today's Pharmaceutical Executive Daily, Bayer agrees to acquire Perfuse Therapeutics for up to $2.45 billion and Madrigal obtains an exclusive global license for a precision siRNA therapy targeting a key genetic driver of MASH, Zentalis Pharmaceuticals announces the first patient dosed in a Phase III trial and Brooke Ervin argues that translating real-world evidence into commercial and clinical impact in urology requires more than access to data.

en-us

3:41

Pharmaceutical Executive Daily: BioNTech Reports 2026...

Pharmaceutical Executive ·

2026/05/05

In today's Pharmaceutical Executive Daily, Cellenkos announces FDA clearance of its investigational new drug application for CK0802, BioNTech releases its first quarter 2026 financial results, and Peter Harbin argues that biopharma's longstanding deciling-based sales targeting model is overdue for a fundamental rethink.

en-us

2:40

Pharmaceutical Executive Daily: UCB to Acquire Candid...

Pharmaceutical Executive ·

2026/05/04

In today's Pharmaceutical Executive Daily, UCB announces a definitive agreement to acquire Candid Therapeutics for up to $2.2 billion, a new commentary by Jeremy Richardson argues that MFN pricing and shifting policy expectations are making affordable direct-to-patient programs at scale an operational necessity rather than a strategic option, and a new article examines how a customer-based process can synchronize sales and marketing organizations for competitive advantage in pharma.

en-us

2:52

Pharmaceutical Executive Daily: FDA Approves Auvelity

Pharmaceutical Executive ·

2026/05/01

In today's Pharmaceutical Executive Daily, the FDA's Oncologic Drugs Advisory Committee votes a favorable benefit-risk profile for AstraZeneca's Truqap, FDA approves Axsome Therapeutics' Auvelity, and Pharmaceutical Executive speaks with Jeff Golfman on how global disruptions are cascading through the pharmaceutical supply chain.

en-us

2:54

Pharmaceutical Executive Daily: Sanofi Appoints Belén...

Pharmaceutical Executive ·

2026/04/30

In today’s Pharmaceutical Executive Daily, Sanofi formally confirms its CEO leadership following a shareholder vote, US prescription drug spending is projected to surpass $1 trillion in 2026, and Inizio launches a next-generation hub services model aimed at simplifying patient access and support.

en-us

3:13

Pharmaceutical Executive Daily: Rocket...

Pharmaceutical Executive ·

2026/04/29

In today's Pharmaceutical Executive Daily, Rocket Pharmaceuticals announces a $180 million sale of its rare pediatric disease priority review voucher, Teva Pharmaceutical enters a definitive agreement to acquire Emalex Biosciences for up to $900 million, and a feature article examines the pharmaceutical supply chain risks converging around the Strait of Hormuz.

en-us

2:47

Pharmaceutical Executive Daily: FDA Approves Breztri

Pharmaceutical Executive ·

2026/04/28

In today's Pharmaceutical Executive Daily, we cover Sun Pharma and IMG Pharma's respective acquisitions, FDA's approval of AstraZeneca's Breztri, and a new feature examining why Ireland has become one of the pharmaceutical industry's most strategically important global manufacturing hubs.

en-us

462 results

Similar Podcasts

Rabbit Hole of Research

Jotham Austin, II PhD, Nick Elizalde,...

La Science CQFD

France Culture

Planetary Radio: Space Exploration, Astronomy and Science

The Planetary Society

aboutlogic

Deniz Sarikaya, Thorsten Altenkirch

The 365 Days of Astronomy

365DaysOfAstronomy.org